%PDF-1.4
%
42 0 obj
<>
endobj
54 0 obj
<>stream
2021-06-29T23:00:45Z
Word
2024-03-28T14:19:04-07:00
2024-03-28T14:19:04-07:00
Mac OS X 10.12.6 Quartz PDFContext
application/pdf
Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial
uuid:c891d743-1dd1-11b2-0a00-fd0827edca00
uuid:c891d748-1dd1-11b2-0a00-380000000000
endstream
endobj
2 0 obj
<>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
5 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
6 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
8 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
77 0 obj
[79 0 R]
endobj
78 0 obj
<>stream
HW{o_@&YƸ9k+Jr|ɝvHT.Bd0>`Wk&?ZƓ`M>
*#SYa-lƍtMGOF_^O:ZJ$57@Y"e\UˬHoő: nؑ=\#]WˎOx0\ܙ48ōE%Z)uRQMJTQR'^?zSUG0y s|RפY0ЍO?nɳOPyU1<]"ˍ"'1&8"~}qA~@@#>[0R)%x<|
EBLmv:,s[JF%ϴO\Hd4%'HBBk&-*ѻ@tUO -A0.|ń{կRY:YR]<,]}&H)F<ȷpc39JYE.2lM _7f}2sZ=v'MP7JfUj?yftUI~dxr}D=(ʥ*Fمϛ4% LȘOib4F*vj<ߏFSm2MJb-)_=}$i`9s#Ll/E
t˖OZMܶ67V]-
0G`ziQ\;A=5q!#qɸtI?9I̤p@}BmN
Fjs7Hmf%㗱-ȶHo9
3LP_Ex5v2, EBWqn()o-%'ko?/?HyMh^J
MP=GLHNpMB`Q+w[!XHQ\y 711JSa]@r4#wjJ m\9({:R)!+U,4?JUjƆAWJ_Zm}lOBs#CҴy
kN$R];y*~zû~~mx5Wlw˸t>Di1+p'u:Mn3vt
ri5턵"HoќEI1K*e iձ=fH܁[ډ}Բ㦺In6!hÚB T]g&7i"6[
ɥEKpOͳwepd8;Ckk6 ѵV"Y%ouXow'52vxȫ9%kc2]d8fHAc7q&{B5ZQgf߷m
v^Q "qqtw[8{Cut&}
1cpN8+vBc~8{˭&E#E+kW]3s#sžq